Behavioral activating effects of adrafinil in aged canines

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 2, 2000, Pages 293-300

  Siwak, C T ^a   Gruet, P ^b   Woehrle F ^b   Schneider, M ^b   Muggenburg, B A ^c   Murphey, H L ^c   Callahan, H ^a   Milgram, N W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Specialites Pharmaceutiques V   (France)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Adrafinil; Aging; Canine; Locomotor activity; Modafinil; Spontaneous open field behavior

Indexed keywords

ADRAFINIL; MODAFINIL; PLACEBO;

AGING; ALERTNESS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOG; FEMALE; LOCOMOTION; MALE; MICTURITION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SNIFFING; STEREOTYPY;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOGS; FEMALE; HYDROXAMIC ACIDS; LOCOMOTION; MALE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0034098359     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00188-X     Document Type: Article

References (34)

1. Bastuji H., Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12:1988;695-700.
2. Burnat P., Robles F., Do B. High-performance liquid chromatographic determination of modafinil and its two metabolites in human plasma using solid-phase extraction. J. Chromatogr. B. Biomed. Sci. Appl. 706:1998;295-304.
3. Cummings B.J., Head E., Ruehl W., Milgram N.W., Cotman C.W. The canine as an animal model of human aging and dementia. Neurobiol. Aging. 17:1996;259-268.
4. Delini-Stula A., Hunn C. Effects of single and repeated treatment with antidepressants on the apomorphine-induced yawning in the rat. The implication of a-1 adrenergic mechanisms in the D-2 receptor function Psychopharmacology (Berlin). 101:1990;62-66.
5. Dewailly P., Durocher A.M., Durot A., Bukowski J.V., Frigard B., Herbin H., Lemaire P., Kohler F., Betrancourt J.C., Lubin S. Adrafinil et ralentissement du sujet âgé institutionnalisé De la significativité statistique à la pertinence clinique (résultat d'une étude multicentrique en double aveugle versus placebo) Acta Med. Interpsychiatrie. 6:1989;1-8.
6. Deyo R.A., Straube K.T., Moyer J.R., Disterhoft J.F. Nimodipine ameliorates aging-related changes in open-field behaviors of the rabbit. Exp. Aging Res. 15:1989;169-175.
7. Edgar D.M., Seidel W.F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J. Pharmacol. Exp. Ther. 283:1997;757-769.
8. Ferraro L., Tanganelli S., O'Connor W.T., Antonelli T., Rambert F., Fuxe K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmacol. 306:1996;33-39.
9. Gerhardt G.A., Cass W.A., Henson M., Zhang Z., Ovadia A., Hoffer B.J., Gash D.M. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiol. Aging. 16:1995;939-946.
10. Gold L.H., Balster R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berlin). 126:1996;286-292.
11. Head E., Callahan H., Cummings B.J., Cotman C.W., Ruehl W.W., Muggenburg B.A., Milgram N.W. Open field activity and human interaction as a function of age and breed in dogs. Physiol. Behav. 62:1997;963-971.
12. Head E., Milgram N.W. Changes in spontaneous behaviour in the dog following oral administration of L-deprenyl. Pharmacol. Biochem. Behav. 43:1992;749-757.
13. Hermant J.-F., Rambert F.A., Duteil J. Awakening properties of modafinil. Effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration Psychopharmacology (Berlin). 103:1991;28-32.
14. ® et patients àgés ambulatoires. Efficacité, versus placebo, de l'Adrafinil sur l'éveil dans les activités de las vie quotidienne. Psychol. Med. 21:1989;1235-1255.
15. Lamberty Y., Gower A.J. Age-related changes in spontaneous behavior and learning in NMRI mice from middle to old age. Physiol. Behav. 51:1991;81-88.
16. Levine M.S., Lloyd R.L., Fisher R.S., Hull C.D., Buchwald N.A. Sensory, motor and cognitive alterations in aged cats. Neurobiol. Aging. 8:1987;253-263.
17. Mallory B.S., Roppolo J.R., de Groat W.C. Pharmacological modulation of the pontine micturition center. Brain Res. 546:1991;310-320.
18. Mignot E., Nishino S., Guilleminault C., Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep. 17:1994;436-437.
19. Milhaud C.L., Klein M.J. Effets de l'adrafinil sur l'activité nocturne du macaque rhésus (Macaca mulatta). J. Pharmacol. (Paris). 16:1985;372-380.
20. Mucha R.F., Volkovskis C., Kalant H. Conditioned increases in locomotor activity produced with morphine as an unconditioned stimulus, and the relation of conditioning to acute morphine effect and tolerance. J. Comp. Physiol. Psychol. 95:1981;351-362.
21. Nicolaidis S., De Saint Hilaire Z. Nonamphetamine awakening agent modafinil induces feeding changes in the rat. Brain Res. Bull. 32:1993;87-90.
22. Nishizawa O., Sugaya K., Noto H., Harada T., Tsuchida S. Pontine micturition center in the dog. J. Urol. 140:1988;872-874.
23. 1H-NMR study Brain Res. 693:1995;251-256.
24. Rambert F.A., Pessonnier J., De Sereville J.-E., Pointeau A.-M., Duteil J. Profil psychopharmacologique originil de l'adrafinil chez la souris. J. Pharmacol. (Paris). 17:1986;37-52.
25. Rambert, F. A.; Pessonnier, J.; Duteil, J.: Several aspects of adrafinil-induced activity in the mouse: Involvement of an alpha-adrenergic link. Proceedings of the 14th CINP Congress, Florence Abstract P.177; June 19-24 1984.
26. Randrup A., Munkvad I. Stereotyped behavior. Pharmacol. Ther. B. 1:1975;757-768.
27. Rosenthal M.J., Varela M., Garcia A., Britton D.R. Age-related changes in the motor response to environmental novelty in the rat. Exp. Gerontol. 24:1989;149-157.
28. Saletu B., Grunberger J., Linzmayer L., Stohr H. Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (Adrafinil) in elderlies. New Trends Exp. Clin. Psychiatry. 2:1986;5-31.
29. Simon P., Hemet C., Costentin J. Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats. Fundam. Clin. Pharmacol. 10:1996;431-435.
30. Simon P., Hemet C., Ramassamy C., Costentin J. Non-amphetamine mechanism of stimulant locomotor effect of modafinil in mice. Eur. Neuropsychopharmacol. 5:1995;509-514.
31. Tanganelli S., Fuxe K., Ferraro L., Janson A.M., Bianchi C. Inhibitory effects of the psychoactive drug modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;461-465.
32. Touret M., Sallanon-Moulin M., Jouvet M. Awakening properties of modafinil without paradoxical sleep rebound. Comparative study with amphetamine in the rat Neurosci. Lett. 189:1995;43-46.
33. Touret M., Sallanon-Moulin M., Fages C., Roudier V., Didier-Bazes M., Roussel B., Tardy M., Jouvet M. Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain. Brain Res. Mol. Brain Res. 26:1994;123-128.
34. Vezina P., Stewart J. Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA. Pharmacol. Biochem. Behav. 20:1984;925-934.